NCT05842642

Brief Summary

Headaches are the fourth cause/reason for disability in the world population. Of which, headache in general accounts for 47%, 38% are tension headaches, 10% migraines and 3% for chronic headache lasting more than 15 days a month. Migraine is a neurological disease/disorder originating in the central nervous system with difficulty modulating responses to common sensory stimuli. Different studies have linked possible oculomotor problems and headaches, being an important and complex relationship. It is difficult to find a suitable and beneficial treatment for the treatment of migraine. It is hypothesized that adding a treatment of manual therapy and therapeutic exercise of the oculomotor system to an already established protocol of manual therapy and therapeutic exercise of the cervical region, has an additional benefit for patients with migraines (in relation to the quality of life, symptomatology and functionality).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 7, 2023

Completed
2 months until next milestone

Study Start

First participant enrolled

April 3, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

May 6, 2023

Completed
24 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2023

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 15, 2023

Completed
Last Updated

September 18, 2023

Status Verified

September 1, 2023

Enrollment Period

2 months

First QC Date

February 7, 2023

Last Update Submit

September 15, 2023

Conditions

Keywords

migraineoculomotormanual therapycervical

Outcome Measures

Primary Outcomes (1)

  • Changes in the impact

    Using the Headache Impact Test (HIT-6) Questionnaire

    Baseline, 6 weeks and 3 months after intervention

Secondary Outcomes (15)

  • Changes in the pain

    Baseline, 6 weeks and 3 months after intervention

  • Changes in the disability

    Baseline, 6 weeks and 3 months after intervention

  • Changes in the depression

    Baseline, 6 weeks and 3 months after intervention

  • Changes in the anxiety

    Baseline, 6 weeks and 3 months after intervention

  • Changes in the sleep quality

    Baseline, 6 weeks and 3 months after intervention

  • +10 more secondary outcomes

Study Arms (2)

Cervical treatment

PLACEBO COMPARATOR

A treatment of the cervical region will be done for 6 weeks, once a week, and they will be taught exercises to do at home.

Other: Cervical

Oculomotor treatment

EXPERIMENTAL

An oculomotor treatment will be added to the treatment of the cervical group with specific exercises in the area. Once a week during 6 weeks

Other: CervicalOther: Oculomotor

Interventions

6 weeks of treatment

Cervical treatmentOculomotor treatment

6 weeks of treatment

Oculomotor treatment

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age between 18-65 years
  • Suffer less than 15 days of headache per month,
  • The pain must have these characteristics: unilateral, pulsating, of moderate to severe intensity, during the attack, nausea and/or vomiting, with the possible presence of an aura
  • History of evolution of more than a year,
  • Onset and aggravation in the afternoon and
  • Relation to visual work
  • Feeling of eye discomfort,
  • Photophobia
  • Neck pain after attack.

You may not qualify if:

  • Receiving some type of preventive physiotherapy treatment at the time of the intervention
  • Subjects with preventive medication, pregnancy or lactation, with neurological, systemic or psychiatric disorders, suffering from bone degeneration
  • Metabolic or musculoskeletal problems that could imply risk of the vertebral artery
  • Dizziness
  • Unbalanced tension
  • Use of specific medication
  • Lack of fluency in Spanish.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Physiotherapy clinic

Madrid, Spain

Location

MeSH Terms

Conditions

Migraine Disorders

Interventions

SETX protein, human

Condition Hierarchy (Ancestors)

Headache Disorders, PrimaryHeadache DisordersBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Study Officials

  • Alexander Achalandabaso, PhD

    University of Jaen

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Upon acceptance, each participant will be assigned a treatment group. Before starting the intervention, all the subjects will go to the UAH physiotherapy center for a first visit with the first examiner where personal data will be collected and sociodemographic, psychometric and functional variables will be assessed. At the end of said evaluation, a second examiner gave them the steps to follow to carry out the study. In addition, you will be given a document with a table that will be your migraine diary that you must fill in every day from the start of treatment until the day of the last assessment.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Two groups, a control group and an experimental group. In the control group, a treatment of the cervical region will be done for 6 weeks, once a week, and they will be taught some exercises to do at home. And in the experimental group, the treatment of the control group will be done plus an additional intervention in the oculomotor region together with some specific exercises.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Professor

Study Record Dates

First Submitted

February 7, 2023

First Posted

May 6, 2023

Study Start

April 3, 2023

Primary Completion

May 30, 2023

Study Completion

September 15, 2023

Last Updated

September 18, 2023

Record last verified: 2023-09

Locations